SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $277K invested in Scinai Immunotherapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.72K
2
+$1.02K
3
+$773
4
Credit Agricole
Credit Agricole
France
+$252

Top Sellers

1
-$78.3K
2
-$14.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$137K
2
$131K
3
$3.08K
4
$3.08K
5
$1.26K
6
$252
7
$119
8
$95
9
$29
10
$12
11
$4